Variant report
Variant | esv3504367 |
---|---|
Chromosome Location | chr6:31023203-31023707 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:30710166..30712547-chr6:31022395..31024749,2 | MCF-7 | breast: |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MUC22-1 | chr6:31023589-31023778 | ENSG00000228789.2 |
2 | lnc-MUC22-1 | chr6:31023487-31024251 | ENSG00000228789.2 |
3 | lnc-MUC22-1 | chr6:31021984-31027653 | XLOC_005243 |
4 | lnc-MUC22-1 | chr6:31023487-31024687 | NONHSAT108710 |
5 | lnc-MUC22-1 | chr6:31023487-31024687 | ENSG00000228789 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000137312 | chromatin interactions |
ENSG00000272273 | chromatin interactions |
ENSG00000137331 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113017263 | chr6:31023203-31023204 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs560474172 | chr6:31023222-31023223 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs539827204 | chr6:31023232-31023233 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs182729775 | chr6:31023250-31023251 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs200308424 | chr6:31023262-31023263 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs566975287 | chr6:31023418-31023419 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs373611095 | chr6:31023426-31023427 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs534096507 | chr6:31023468-31023469 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs555981526 | chr6:31023471-31023472 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs187914233 | chr6:31023472-31023473 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs544916984 | chr6:31023487-31023488 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs190880192 | chr6:31023496-31023497 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs72847064 | chr6:31023503-31023504 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs563991329 | chr6:31023604-31023605 | Weak transcription Enhancers Active TSS | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs528175551 | chr6:31023624-31023625 | Weak transcription Enhancers Active TSS | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs539969853 | chr6:31023629-31023630 | Weak transcription Enhancers Active TSS | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs561544340 | chr6:31023651-31023652 | Weak transcription Enhancers Active TSS | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs146025713 | chr6:31023654-31023655 | Weak transcription Enhancers Active TSS | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs139184690 | chr6:31023656-31023657 | Weak transcription Enhancers Active TSS | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs529096521 | chr6:31023705-31023706 | Weak transcription Enhancers Active TSS | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs550417600 | chr6:31023707-31023708 | Weak transcription Enhancers Active TSS | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Breast cancer | 21364760 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:31009600-31027400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr6:31022000-31023800 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr6:31022200-31024600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr6:31022200-31024800 | Weak transcription | Brain Germinal Matrix | brain |
5 | chr6:31022200-31025400 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr6:31022200-31025400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
7 | chr6:31022200-31025400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr6:31022200-31027000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr6:31022200-31050800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr6:31022400-31024200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr6:31022400-31024400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
12 | chr6:31022400-31024800 | Weak transcription | Brain Anterior Caudate | brain |
13 | chr6:31022400-31026600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr6:31022600-31026400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr6:31022600-31028200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
16 | chr6:31022800-31026600 | Enhancers | NHEK | skin |
17 | chr6:31023200-31023400 | Enhancers | HSMMtube | muscle |
18 | chr6:31023200-31027600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
19 | chr6:31023200-31028200 | Enhancers | HMEC | breast |
20 | chr6:31023600-31024000 | Active TSS | Esophagus | oesophagus |
21 | chr6:31023600-31024600 | Weak transcription | HSMMtube | muscle |